LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Article ; Online: Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance.

    Murphy, Jane / Kirk, Claire W / Lambert, Deborah M / McGorrian, Catherine / Walsh, Roddy / McVeigh, Terri P / Prendiville, Terence / Ward, Deirdre / Galvin, Joseph / Lynch, Sally Ann

    Irish journal of medical science

    2024  

    Abstract: Background: Inherited cardiomyopathies (HCM, DCM, ACM) and cardiac ion channelopathies (long QT/Brugada syndromes, CPVT) are associated with significant morbidity and mortality; however, diagnosis of a familial pathogenic variant in a proband allows for ...

    Abstract Background: Inherited cardiomyopathies (HCM, DCM, ACM) and cardiac ion channelopathies (long QT/Brugada syndromes, CPVT) are associated with significant morbidity and mortality; however, diagnosis of a familial pathogenic variant in a proband allows for subsequent cascade screening of their at-risk relatives.
    Aims: We investigated the diagnostic yield from cardiac gene panel testing and reviewed variants of uncertain significance from patients attending three specialist cardiogenetics services in Ireland in the years 2002 to 2020.
    Results: Reviewing molecular genetic diagnostic reports of 834 patients from 820 families, the initial diagnostic yield of pathogenic/likely pathogenic variants was 237/834 patients (28.4%), increasing to 276/834 patients (33.1%) following re-evaluation of cases with variant(s) of uncertain significance. Altogether, 42/85 patients with VUS reviewed (49.4%) had a re-classification that could change their clinical management. Females were more likely to carry pathogenic/likely pathogenic variants than males (139/374, 37.2% vs 137/460, 29.8%, respectively, p = 0.03), and the diagnostic yields were highest in the 0 to < 2 years age group (6/12, 50.0%) and amongst those tested for cardiomyopathy gene panels (13/35, 37.1%). Variants in the MYBPC3/MYH7 (87/109, 79.8%) and KCNQ1/KCNH2 (91/100, 91.0%) genes were the predominant genetic causes for hypertrophic cardiomyopathy and long QT syndrome, respectively.
    Conclusion: Our study highlights the importance of collation and review of pre-ACMG genetic variants to increase diagnostic utility of genetic testing for inherited heart disease. Almost half of patients with pre-ACMG VUS reviewed had their variant re-classified to likely pathogenic/likely benign which resulted in a positive clinical impact for patients and their families.
    Language English
    Publishing date 2024-03-15
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 390895-1
    ISSN 1863-4362 ; 0021-1265
    ISSN (online) 1863-4362
    ISSN 0021-1265
    DOI 10.1007/s11845-024-03650-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Developmental Regulation and Functional Prediction of microRNAs in an Expanded

    Herron, Caoimhe M / O'Connor, Anna / Robb, Emily / McCammick, Erin / Hill, Claire / Marks, Nikki J / Robinson, Mark W / Maule, Aaron G / McVeigh, Paul

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 811123

    Abstract: The liver fluke, ...

    Abstract The liver fluke,
    MeSH term(s) Animals ; Extracellular Vesicles ; Fasciola hepatica/genetics ; Leukocytes, Mononuclear ; MicroRNAs/genetics
    Chemical Substances MicroRNAs
    Language English
    Publishing date 2022-02-10
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.811123
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway.

    Scarth, Morgan / Havnes, Ingrid A / Jørstad, Marie L / McVeigh, Jim / Van Hout, Marie Claire / Westlye, Lars T / Torgersen, Svenn / Bjørnebekk, Astrid

    Drug and alcohol dependence

    2022  Volume 231, Page(s) 109275

    Abstract: Introduction: Anabolic androgenic steroids (AAS), including testosterone and synthetic derivatives, are typically used to increase muscle mass. Many users develop a dependence on these substances, contributing to worsened physical and mental health ... ...

    Abstract Introduction: Anabolic androgenic steroids (AAS), including testosterone and synthetic derivatives, are typically used to increase muscle mass. Many users develop a dependence on these substances, contributing to worsened physical and mental health outcomes. Aspects of personality and executive dysfunction may represent underlying vulnerabilities for developing dependence.
    Objective: To identify levels of AAS dependence within substance use disorder (SUD) treatment patients and assess the relationship between dependence severity and personality traits and executive function (EF).
    Methods: Data were collected from patients at 38 SUD treatment facilities in Norway. Questionnaires were completed for measures of personality and EF. Measures of symptoms of AAS dependence were used in latent class analysis to identify sub-groups of patients, which were evaluated for association with EF and personality traits, and compared with a group of non-AAS using SUD patients.
    Results: Three classes were identified; largely reflecting low, moderate, and high symptoms of dependence. Multinomial regression analyses indicated that moderate and high symptoms were associated with several measures of EF and personality traits, particularly self-monitoring, antagonism, disinhibition, and rigid perfectionism while users with low symptoms exhibited higher capacities for emotional control and shift, and lower negative affectivity, relative to non-AAS using SUD patients. Backward stepwise regressions indicated antagonism, and decreased self-monitoring as key personality and cognitive characteristics of SUD patients with severe AAS dependence.
    Conclusion: Our findings indicate that specific executive dysfunctions and personality features, particularly those associated with poor emotional control, reduced empathy, and impulsivity are associated with more severe AAS dependence in the SUD population.
    MeSH term(s) Anabolic Agents/adverse effects ; Executive Function ; Humans ; Personality ; Substance-Related Disorders/epidemiology ; Substance-Related Disorders/psychology ; Testosterone Congeners/adverse effects
    Chemical Substances Anabolic Agents ; Testosterone Congeners
    Language English
    Publishing date 2022-01-10
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 519918-9
    ISSN 1879-0046 ; 0376-8716
    ISSN (online) 1879-0046
    ISSN 0376-8716
    DOI 10.1016/j.drugalcdep.2022.109275
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey.

    Allen, Sophie / Loong, Lucy / Garrett, Alice / Torr, Bethany / Durkie, Miranda / Drummond, James / Callaway, Alison / Robinson, Rachel / Burghel, George J / Hanson, Helen / Field, Joanne / McDevitt, Trudi / McVeigh, Terri P / Bedenham, Tina / Bowles, Christopher / Bradshaw, Kirsty / Brooks, Claire / Butler, Samantha / Del Rey Jimenez, Juan Carlos /
    Hawkes, Lorraine / Stinton, Victoria / MacMahon, Suzanne / Owens, Martina / Palmer-Smith, Sheila / Smith, Kenneth / Tellez, James / Valganon-Petrizan, Mikel / Waskiewicz, Erik / Yau, Michael / Eccles, Diana M / Tischkowitz, Marc / Goel, Shilpi / McRonald, Fiona / Antoniou, Antonis C / Morris, Eva / Hardy, Steven / Turnbull, Clare

    Journal of medical genetics

    2024  Volume 61, Issue 4, Page(s) 305–312

    Abstract: Background: National and international amalgamation of genomic data offers opportunity for research and audit, including analyses enabling improved classification of variants of uncertain significance. Review of individual-level data from National ... ...

    Abstract Background: National and international amalgamation of genomic data offers opportunity for research and audit, including analyses enabling improved classification of variants of uncertain significance. Review of individual-level data from National Health Service (NHS) testing of cancer susceptibility genes (2002-2023) submitted to the National Disease Registration Service revealed heterogeneity across participating laboratories regarding (1) the structure, quality and completeness of submitted data, and (2) the ease with which that data could be assembled locally for submission.
    Methods: In May 2023, we undertook a closed online survey of 51 clinical scientists who provided consensus responses representing all 17 of 17 NHS molecular genetic laboratories in England and Wales which undertake NHS diagnostic analyses of cancer susceptibility genes. The survey included 18 questions relating to 'next-generation sequencing workflow' (11), 'variant classification' (3) and 'phenotypical context' (4).
    Results: Widely differing processes were reported for transfer of variant data into their local LIMS (Laboratory Information Management System), for the formatting in which the variants are stored in the LIMS and which classes of variants are retained in the local LIMS. Differing local provisions and workflow for variant classifications were also reported, including the resources provided and the mechanisms by which classifications are stored.
    Conclusion: The survey responses illustrate heterogeneous laboratory workflow for preparation of genomic variant data from local LIMS for centralised submission. Workflow is often labour-intensive and inefficient, involving multiple manual steps which introduce opportunities for error. These survey findings and adoption of the concomitant recommendations may support improvement in laboratory dataflows, better facilitating submission of data for central amalgamation.
    MeSH term(s) Humans ; Workflow ; Laboratories ; State Medicine ; Genomics ; Neoplasms ; United Kingdom
    Language English
    Publishing date 2024-03-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmg-2023-109645
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre-Heart Failure With Preserved Ejection Fraction: The PARABLE Randomized Clinical Trial.

    Ledwidge, Mark / Dodd, Jonathan D / Ryan, Fiona / Sweeney, Claire / McDonald, Katherine / Fox, Rebecca / Shorten, Elizabeth / Zhou, Shuaiwei / Watson, Chris / Gallagher, Joseph / McVeigh, Niall / Murphy, David J / McDonald, Kenneth

    JAMA cardiology

    2023  Volume 8, Issue 4, Page(s) 366–375

    Abstract: Importance: Pre-heart failure with preserved ejection fraction (pre-HFpEF) is common and has no specific therapy aside from cardiovascular risk factor management.: Objective: To investigate the hypothesis that sacubitril/valsartan vs valsartan would ... ...

    Abstract Importance: Pre-heart failure with preserved ejection fraction (pre-HFpEF) is common and has no specific therapy aside from cardiovascular risk factor management.
    Objective: To investigate the hypothesis that sacubitril/valsartan vs valsartan would reduce left atrial volume index using volumetric cardiac magnetic resonance imaging in patients with pre-HFpEF.
    Design, setting, and participants: The Personalized Prospective Comparison of ARNI [angiotensin receptor/neprilysin inhibitor] With ARB [angiotensin-receptor blocker] in Patients With Natriuretic Peptide Elevation (PARABLE) trial was a prospective, double-blind, double-dummy, randomized clinical trial carried out over 18 months between April 2015 and June 2021. The study was conducted at a single outpatient cardiology center in Dublin, Ireland. Of 1460 patients in the STOP-HF program or outpatient cardiology clinics, 461 met initial criteria and were approached for inclusion. Of these, 323 were screened and 250 asymptomatic patients 40 years and older with hypertension or diabetes, elevated B-type natriuretic peptide (BNP) greater than 20 pg/mL or N-terminal pro-b-type natriuretic peptide greater than 100 pg/mL, left atrial volume index greater than 28 mL/m2, and preserved ejection fraction greater than 50% were included.
    Interventions: Patients were randomized to angiotensin receptor neprilysin inhibitor sacubitril/valsartan titrated to 200 mg twice daily or matching angiotensin receptor blocker valsartan titrated to 160 mg twice daily.
    Main outcomes and measures: Maximal left atrial volume index and left ventricular end diastolic volume index, ambulatory pulse pressure, N-terminal pro-BNP, and adverse cardiovascular events.
    Results: Among the 250 participants in this study, the median (IQR) age was 72.0 (68.0-77.0) years; 154 participants (61.6%) were men and 96 (38.4%) were women. Most (n = 245 [98.0%]) had hypertension and 60 (24.0%) had type 2 diabetes. Maximal left atrial volume index was increased in patients assigned to receive sacubitril/valsartan (6.9 mL/m2; 95% CI, 0.0 to 13.7) vs valsartan (0.7 mL/m2; 95% CI, -6.3 to 7.7; P < .001) despite reduced markers of filling pressure in both groups. Changes in pulse pressure and N-terminal pro-BNP were lower in the sacubitril/valsartan group (-4.2 mm Hg; 95% CI, -7.2 to -1.21 and -17.7%; 95% CI, -36.9 to 7.4, respectively; P < .001) than the valsartan group (-1.2 mm Hg; 95% CI, -4.1 to 1.7 and 9.4%; 95% CI, -15.6 to 4.9, respectively; P < .001). Major adverse cardiovascular events occurred in 6 patients (4.9%) assigned to sacubitril/valsartan and 17 (13.3%) assigned to receive valsartan (adjusted hazard ratio, 0.38; 95% CI, 0.17 to 0.89; adjusted P = .04).
    Conclusions and relevance: In this trial of patients with pre-HFpEF, sacubitril/valsartan treatment was associated with a greater increase in left atrial volume index and improved markers of cardiovascular risk compared to valsartan. More work is needed to understand the observed increased cardiac volumes and long-term effects of sacubitril/valsartan in patients with pre-HFpEF.
    Trial registration: ClinicalTrials.gov Identifier: NCT04687111.
    MeSH term(s) Male ; Humans ; Female ; Aged ; Heart Failure/diagnostic imaging ; Heart Failure/drug therapy ; Heart Failure/chemically induced ; Natriuretic Peptide, Brain ; Angiotensin Receptor Antagonists ; Neprilysin ; Diabetes Mellitus, Type 2/drug therapy ; Tetrazoles/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Stroke Volume ; Valsartan/therapeutic use ; Heart Atria ; Hypertension/drug therapy
    Chemical Substances Natriuretic Peptide, Brain (114471-18-0) ; sacubitril (17ERJ0MKGI) ; Angiotensin Receptor Antagonists ; Neprilysin (EC 3.4.24.11) ; Tetrazoles ; Angiotensin-Converting Enzyme Inhibitors ; Valsartan (80M03YXJ7I)
    Language English
    Publishing date 2023-03-07
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2380-6591
    ISSN (online) 2380-6591
    DOI 10.1001/jamacardio.2023.0065
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

    Brennan, Rebekah / Wazaify, Mayyada / Shawabkeh, Haneen / Boardley, Ian / McVeigh, Jim / Van Hout, Marie Claire

    Drug safety

    2021  Volume 44, Issue 9, Page(s) 917–928

    Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used medications worldwide and have analgesic, antipyretic and anti-inflammatory properties. Although NSAIDs are recognised as generally safe and effective, non-medical and extra- ... ...

    Abstract Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used medications worldwide and have analgesic, antipyretic and anti-inflammatory properties. Although NSAIDs are recognised as generally safe and effective, non-medical and extra-medical use of these products can occur. Unlike the use of illegal and many prescription drugs, which are subject to extensive research attention, inappropriate use of NSAIDs has been less well investigated. This scoping review collates and describes what is known regarding non-medical and extra-medical use of NSAIDs. In total, 72 studies were included in this scoping review. Three themes emerged from the review: (1) indicative profile of people who engage in non-medical or extra-medical use of NSAIDs; (2) antecedents for non-medical or extra-medical use; and (3) adverse health effects of non-medical and extra-medical use of NSAIDs. The review concluded that there is a need for enhanced patient education, including among sports people; pharmacovigilance in terms of clinician recognition of aberrance; and prescriber and pharmacist awareness of the potential for extra-medical and non-medical use and the related health harms.
    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Drug-Related Side Effects and Adverse Reactions ; Humans ; Pharmacovigilance
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal
    Language English
    Publishing date 2021-07-30
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 1018059-x
    ISSN 1179-1942 ; 0114-5916
    ISSN (online) 1179-1942
    ISSN 0114-5916
    DOI 10.1007/s40264-021-01085-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.

    McVeigh, Terri Patricia / Sweeney, Karl J / Brennan, Donal J / McVeigh, Una M / Ward, Simon / Strydom, Ann / Seal, Sheila / Astbury, Katherine / Donnellan, Paul / Higgins, Joanne / Keane, Maccon / Kerin, Michael J / Malone, Carmel / McGough, Pauline / McLaughlin, Ray / O'Leary, Michael / Rushe, Margaret / Barry, Michael Kevin / MacGregor, Geraldine /
    Sugrue, Michael / Yousif, Ala / Al-Azawi, Dhafir / Berkeley, Eileen / Boyle, Terence J / Connolly, Elizabeth M / Nolan, Carmel / Richardson, Elaine / Giffney, Claire / Doyle, Samantha B / Broderick, Sheila / Boyd, William / McVey, Ruaidhri / Walsh, Thomas / Farrell, Michael / Gallagher, David J / Rahman, Nazneen / George, Angela J

    Familial cancer

    2022  Volume 22, Issue 2, Page(s) 135–149

    Abstract: In the Republic of Ireland (ROI), BRCA1/BRCA2 genetic testing has been traditionally undertaken in eligible individuals, after pre-test counselling by a Clinical Geneticist/Genetic Counsellor. Clinical Genetics services in ROI are poorly resourced, with ... ...

    Abstract In the Republic of Ireland (ROI), BRCA1/BRCA2 genetic testing has been traditionally undertaken in eligible individuals, after pre-test counselling by a Clinical Geneticist/Genetic Counsellor. Clinical Genetics services in ROI are poorly resourced, with routine waiting times for appointments at the time of this pilot often extending beyond a year. The consequent prolonged waiting times are unacceptable where therapeutic decision-making depends on the patient's BRCA status. "Mainstreaming" BRCA1/BRCA2 testing through routine oncology/surgical clinics has been implemented successfully in other centres in the UK and internationally. We aimed to pilot this pathway in three Irish tertiary centres. A service evaluation project was undertaken over a 6-month period between January and July 2017. Eligible patients, fulfilling pathology and age-based inclusion criteria defined by TGL clinical, were identified, and offered constitutional BRCA1/BRCA2 testing after pre-test counselling by treating clinicians. Tests were undertaken by TGL Clinical. Results were returned to clinicians by secure email. Onward referrals of patients with uncertain/pathogenic results, or suspicious family histories, to Clinical Genetics were made by the treating team. Surveys assessing patient and clinician satisfaction were sent to participating clinicians and a sample of participating patients. Data was collected with respect to diagnostic yield, turnaround time, onward referral rates, and patient and clinician feedback. A total of 101  patients underwent diagnostic germline BRCA1/BRCA2 tests through this pathway. Pathogenic variants were identified in 12 patients (12%). All patients in whom variants were identified were appropriately referred to Clinical Genetics. At least 12 additional patients with uninformative BRCA1/BRCA2 tests were also referred for formal assessment by Clinical Geneticist or Genetic Counsellor. Issues were noted in terms of time pressures and communication of results to patients. Results from a representative sample of participants completing the satisfaction survey indicated that the pathway was acceptable to patients and clinicians. Mainstreaming of constitutional BRCA1/BRCA2 testing guided by age- and pathology-based criteria is potentially feasible for patients with breast cancer as well as patients with ovarian cancer in Ireland.
    MeSH term(s) Humans ; Female ; Genetic Testing ; Pilot Projects ; Ireland ; Feasibility Studies ; BRCA2 Protein/genetics ; BRCA1 Protein/genetics ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/genetics ; Breast Neoplasms/diagnosis ; Breast Neoplasms/genetics ; Genetic Predisposition to Disease ; Germ-Line Mutation
    Chemical Substances BRCA2 Protein ; BRCA1 Protein ; BRCA1 protein, human ; BRCA2 protein, human
    Language English
    Publishing date 2022-08-27
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1502496-9
    ISSN 1573-7292 ; 1389-9600
    ISSN (online) 1573-7292
    ISSN 1389-9600
    DOI 10.1007/s10689-022-00313-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Exploration of Caregiver Experiences of Conservatively Managed End-Stage Kidney Disease to Inform Development of a Psychosocial Intervention: The ACORN Study Protocol.

    Carswell, Claire / Yaqoob, Magdi / Gilbert, Patricia / Kuan, Ying / Laurente, Gladys / McGuigan, Karen / McKeaveney, Clare / McVeigh, Clare / Reid, Joanne / Rej, Soham / Walsh, Ian / Noble, Helen

    Healthcare (Basel, Switzerland)

    2021  Volume 9, Issue 12

    Abstract: Background: End-stage kidney disease (ESKD) is an overwhelming illness that impacts not just patients, but also their informal carers. Patients who opt for conservative management rather than dialysis experience difficult symptoms and the psychosocial ... ...

    Abstract Background: End-stage kidney disease (ESKD) is an overwhelming illness that impacts not just patients, but also their informal carers. Patients who opt for conservative management rather than dialysis experience difficult symptoms and the psychosocial consequences of their condition. Informal carers of patients who choose conservative management can also experience high levels of psychosocial burden, yet there is little guidance on how best to support informal carers, and no evidence on psychosocial interventions to address unmet needs.
    Aim: The aim of this study is to explore the experiences and unmet needs of informal carers of patients with ESKD receiving conservative management in order to inform the development of a psychosocial intervention.
    Methods: This qualitative study will consist of three stages: (I) semi-structured interviews with informal carers in England and Northern Ireland, (II) focus groups with healthcare professionals and informal carers, and (III) national workshops to refine the components of a psychosocial intervention.
    Discussion: Informal carers of patients with ESKD who are receiving conservative management experience a high psychosocial burden, but there is limited evidence on how best to provide support, particularly as the patient nears the end of life. To our knowledge this study will be the first to address this gap by exploring the experiences and unmet needs of informal carers, with the aim of informing the development of a psychosocial intervention to support the health and wellbeing of informal carers.
    Language English
    Publishing date 2021-12-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2721009-1
    ISSN 2227-9032
    ISSN 2227-9032
    DOI 10.3390/healthcare9121731
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Examining the Acceptability and Feasibility of the Compassionate Mindful Resilience (CMR) Programme in Adult Patients with Chronic Kidney Disease: The COSMIC Study Protocol.

    Wilson, Anna / McKeaveney, Clare / Carswell, Claire / Atkinson, Karen / Burton, Stephanie / McVeigh, Clare / Graham-Wisener, Lisa / Jääskeläinen, Erika / Johnston, William / O'Rourke, Daniel / Reid, Joanne / Rej, Sohem / Walsh, Ian / McArdle, Michael / Noble, Helen

    Healthcare (Basel, Switzerland)

    2022  Volume 10, Issue 8

    Abstract: Kidney disease is often progressive, and patients experience diminished health-related quality of life. In addition, the impact of the coronavirus (COVID-19) pandemic, and its associated restrictions, has brought many additional burdens. It is therefore ... ...

    Abstract Kidney disease is often progressive, and patients experience diminished health-related quality of life. In addition, the impact of the coronavirus (COVID-19) pandemic, and its associated restrictions, has brought many additional burdens. It is therefore essential that effective and affordable systems are explored to improve the psychological health of this group that can be delivered safely during the COVID-19 pandemic. The aim of this study is to support a new service development project in partnership with the UK's leading patient support charity Kidney Care UK by implementing the four-session Compassionate Mindful Resilience (CMR) programme, developed by MindfulnessUK, and explore its effectiveness for patients with stage 4 or 5 chronic kidney disease or have received a kidney transplant. The study will utilise a quasi-experimental, pretest/posttest design to measure the effect of the CMR programme on anxiety, depression, self-compassion, the ability to be mindful, wellbeing, and resilience, using pre- and posttests, alongside a qualitative exploration to explore factors influencing the feasibility, acceptability, and suitability of the intervention, with patients (and the Mindfulness Teacher) and their commitment to practice. Outcomes from this study will include an evidence-based mindfulness and compassion programme for use with people with kidney disease, which is likely to have applicability across other chronic diseases.
    Language English
    Publishing date 2022-07-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2721009-1
    ISSN 2227-9032
    ISSN 2227-9032
    DOI 10.3390/healthcare10081387
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Diagnosis and management of ankylosing spondylitis.

    McVeigh, Claire M / Cairns, Andrew P

    BMJ (Clinical research ed.)

    2006  Volume 333, Issue 7568, Page(s) 581–585

    MeSH term(s) Humans ; Medical History Taking/methods ; Physical Examination/methods ; Referral and Consultation ; Spondylitis, Ankylosing/diagnosis ; Spondylitis, Ankylosing/etiology ; Spondylitis, Ankylosing/therapy
    Language English
    Publishing date 2006-09-16
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.38954.689583.DE
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top